C12N 2710/14041
Use of virus, viral particle or viral elements as a vector
C12N2710/14041 (Use of virus, viral particle or viral elements as a vector) appears on 176 US grants and 288 published applications in this corpus.
Search patents in C12N- Granted patents
- 176
- Published applications
- 288
- Assignees
- 171
- Inventors
- 524
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 4 |
| 2004 | 2 | 2 |
| 2005 | 1 | 2 |
| 2006 | 1 | 4 |
| 2007 | 2 | 3 |
| 2008 | 0 | 6 |
| 2009 | 5 | 7 |
| 2010 | 0 | 6 |
| 2011 | 5 | 8 |
| 2012 | 2 | 6 |
| 2013 | 4 | 5 |
| 2014 | 1 | 12 |
| 2015 | 9 | 24 |
| 2016 | 9 | 17 |
| 2017 | 11 | 17 |
| 2018 | 20 | 13 |
| 2019 | 11 | 14 |
| 2020 | 13 | 26 |
| 2021 | 9 | 21 |
| 2022 | 9 | 21 |
| 2023 | 11 | 15 |
| 2024 | 14 | 24 |
| 2025 | 9 | 20 |
| 2026 | 13 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/14043Viral genome or elements thereof as genetic vectoreIndexing code138
- C12N 2710/14044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code26
- C12N 2710/14042Virus or viral particle as vehicleIndexing code9
- C12N 2710/14045Special targeting system for viral vectorsIndexing code0
Recent patents
- Recombinant adeno-associated virus compositions and methods for producing same8 Sep 2026US 12,729,385 B2Prevail Therapeutics, Inc.
- Baculovirus expression vector4 Aug 2026US 12,697,381 B2Intervet Inc.
- Baculovirus expression system28 Jul 2026US 12,692,481 B2Virovek, Inc.
- Method of producing an immunogenic composition7 Jul 2026US 12,673,094 B2Boehringer Ingelheim Animal Health USA Inc.
- SmartBac baculovirus expression system and application thereof9 Jun 2026US 12,649,931 B2Institute of Biophysics, Chinese Pie Academy of Sciences
- Engineered tet enzymes and use in epigenetics and next generation sequencing (ngs), such as tet-assisted pyridine borane sequencing (taps)1 Oct 2026US 2026/0297543 A1Exact Sciences Innovation LTD.
- Generation of adeno-associated virus capsid libraries for insect cells10 Sep 2026US 2026/0265729 A1uniQure biopharma B.V.
- Gene therapies for lysosomal disorders27 Aug 2026US 2026/0250715 A1Prevail Therapeutics, Inc.
- Method of producing an immunogenic composition30 Jul 2026US 2026/0216312 A1Boehringer Ingelheim Animal Health USA Inc.
- Further improved aav vectors produced in insect cells23 Jul 2026US 2026/0209798 A1uniQure IP B.V.
Most cited
By later US patents
- Penton base protein and methods of using same136US 5,559,099 AGenVec, Inc. · 1996
- Parvovirus protein presenting capsids66US 5,916,563 AUnited States of America · 1999
- Adenoviral-mediated cell targeting commanded by the adenovirus penton base protein58US 5,712,136 AGenVec, Inc. · 1998
- Penton base protein and methods of using same50US 5,731,190 AGenVec, Inc. · 1998
- Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV45US 8,512,981 B2Amsterdam Molecular Therapeutics B.V. · 2013